$0.215600
Comments
Loading...
Antibe Therapeutics (ATBPF) Forecast
NewsEarningsAntibe Therapeutics (ATBPF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAntibe Therapeutics (OTC:ATBPF) Stock Quotes, Forecast and News Summary
Antibe Therapeutics Stock (OTC: ATBPF) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Antibe Therapeutics (ATBPF) stock?
You can purchase shares of Antibe Therapeutics (OTCEM:ATBPF) through any online brokerage.
Who are Antibe Therapeutics (ATBPF) competitors?
There are no as such competitors for Antibe Therapeutics.
What is the forecast, or price target, for Antibe Therapeutics (ATBPF) stock?
There is no analysis for Antibe Therapeutics to provide a consensus price target.
What is the current price for Antibe Therapeutics (ATBPF)?
The stock price for Antibe Therapeutics (OTCEM: ATBPF) is $ last updated .
Does Antibe Therapeutics (ATBPF) pay a dividend?
There are no upcoming dividends for Antibe Therapeutics.
When is Antibe Therapeutics (OTCEM:ATBPF) reporting earnings?
Antibe Therapeutics does not have any upcoming earnings scheduled.
Is Antibe Therapeutics (ATBPF) going to split?
There is no upcoming split for Antibe Therapeutics.
What sector and industry does Antibe Therapeutics (ATBPF) operate in?
Antibe Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCEM.